Anthropic의 새로운 전략: 바이오텍에 도구를 팔고 신약은 직접 개발한다
Anthropic이 'Claude Science'를 출시하고 소외 질환을 위한 신약 발굴 계획을 발표하며, 도구를 파는 회사에서 제약 분야의 직접 경쟁자로 전환하는 신호를 보냈다.
anthropic introduced claude science, an integrated workbench for scientists, and declared its intent to develop proprietary drugs, focusing on neglected diseases. while the firm lists major biotech clients, this move pits it against partners like pfizer and merck, creating a complex vendor-customer dynamic. anthropic provided few details on clinical trials or manufacturing, but this escalation mirrors trends by google's isomorphic labs. the strategy proves that frontier labs are moving beyond text generation into high-stakes, real-world biology applications where failures can cost billions.